DOI号:10.1016/ S2468-1253(26)00109-3
文献链接:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00109-3/abstract
文献作者:Laura R Moolenaar, Mahsoem Ali, Theo J Aufenacker, Geerard L Beets, Robbert J I Bosker, Tineke E Buffart, Jacobus WA Burger, Evelien Dekker, Quentin Denost, Pascal G Doornebosch, Peter van Duijvendijk, Hans F J Fabry, Elisabeth D Geijsen, Michael F Gerhards, Wilhelmina M U van Grevenstein, Brechtje A Grotenhuis, Christiaan Hoff, Jeroen W A Leijtens, Koen C M J Peeters, Apollo Pronk, George P van der Schelling, Colin Sietses, Anke B Smits, Boudewijn R Toorenvliet, Anthony W H van de Ven, Emiel G G Verdaasdonk, Ronald J C L M Vuylsteke, Henderik L van Westreenen, Johannes H W de Wilt, David D E Zimmerman, Marilyne M Lange, Nicole C T van Grieken, Barbara A J Bastiaansen, Roel Hompes, Corrie A Marijnen, Marcel G W Dijkgraaf, Leon M G Moons, Pieter J Tanis, Chris Cunningham, J B Tuynman, on behalf of the TESAR Study Group*
备注信息:要的是文章的Supplementary appendix，Supplementary appendix，Supplementary appendix（重要的事情说三遍！！！！）不要正文，正文已有，非诚勿扰，谢谢！！！ |
50
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial
